HANS BIOMED CORPORATION
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
As of 2026-10-10, HANS BIOMED CORPORATION has 150 Korean MFDS device approvals, 6 US FDA clearances/approvals, 2 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1999 and listed on KOSDAQ in 2009, Hans Biomed is a human tissue implant and medical device company. It produces skin and bone tissue implants Bella Cell HD and SureFuse, and medical devices including Mint and hair transplant devices, alongside silicone materials and affiliate cosmeceutical products. Tissue implant products account for about 61% of revenue and medical devices about 32%, with headquarters in Songpa-gu, Seoul, R&D and production facilities in Daejeon, and overseas subsidiaries in the US, Thailand, and the UK.
Products & technology
- Bella Cell HDskin tissue implant
- SureFusebone tissue implant
- Mintmedical device
- hair transplant devicehair transplantation medical device
Regulatory approvals
data.go.kr · openFDA150 Korean MFDS device approvals · 1999–2026 / 6 US FDA 510(k) · 2016–2026
- FDAMINT MONO Sutures2026-09-18
- MFDSImplantation assistant, inserter2026-08-11Product approval · Class 1제신 26-993 호
- MFDSBarrier, intra oral, resorbable2026-01-29Product approval · Class 4제허 26-90 호
- MFDSImplantation assistant, inserter2025-10-28Product approval · Class 1제신 25-1426 호
- MFDSBone graft material, human source2025-09-09Product approval · Class 4제허 25-619 호
- MFDSPolydioxanone suture2025-07-16Product approval · Class 4제허 25-474 호
- MFDSPolydioxanone suture2025-06-26Product approval · Class 4제허 25-419 호
- MFDSDressing, fluid-impermeable film2025-04-28Product approval · Class 2제인 25-4357 호
- MFDSimplant, endosseous, fixtureRevoked2025-03-10Product approval · Class 3제허 25-143 호
- MFDSIrrigation syringeRevoked2025-02-12Product approval · Class 1제신 25-145 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2024-11-12Product approval · Class 4제허 24-784 호
- MFDSBone graft, human sourceRevoked2024-08-14Product approval · Class 4제허 24-554 호
Show 68 more
- MFDSBone graft, human sourceRevoked2024-08-14Product approval · Class 4제허 24-553 호
- MFDSNeedle, aspiration/injection, reusable2024-05-24Product approval · Class 1제신 24-646 호
- MFDSBone graft, human sourceRevoked2024-03-20Product approval · Class 4제허 24-202 호
- MFDSBone graft, human sourceRevoked2024-03-20Product approval · Class 4제허 24-201 호
- MFDSDressing, fluid-impermeable film2024-02-14Product approval · Class 2제인 24-162 호
- MFDSPolydioxanone suture2023-08-07Product approval · Class 4제허 23-824 호
- MFDSHemostat, internal, absorbable2023-06-29Product approval · Class 4제허 23-731 호
- MFDSPolyglycolic acid suture2023-05-31Product approval · Class 4제허 23-629 호
- MFDSSuture, polyglecaprone2023-05-31Product approval · Class 4제허 23-622 호
- MFDSDressing, topical hemostasis, externalRevoked2023-03-29Product approval · Class 2제인 23-4593 호
- FDAMINT Product Family (Including MINT, MINT Lift, and MINT-I Sutures), MINT Lift ML 1043, MINT Lift ML 1013, MINT Lift 1019, MINT Lift Mini 10142023-03-07
- MFDSNeedle, suture, general-purpose2023-02-13Product approval · Class 1제신 23-175 호
- MFDSPolydioxanone suture2022-10-28Product approval · Class 4제허 22-726 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2022-01-24Product approval · Class 4제허 22-50 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2022-01-24Product approval · Class 4제허 22-49 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2022-01-06Product approval · Class 4제허 22-8 호
- MFDSBreast prosthesis, internal, gel-filledRevoked2021-09-24Product approval · Class 4제허 21-787 호
- MFDSNeedle, suture, general-purpose2021-08-04Product approval · Class 1제신 21-1063 호
- MFDSSurgical suture, non-absorbable, with/without needle2021-06-10Product approval · Class 3제허 21-467 호
- MFDSImplantation assistant, inserter2021-05-14Product approval · Class 1제신 21-678 호
- MFDSTissue supplement, collagen2021-01-26Product approval · Class 4제허 21-63 호
- MFDSTissue supplement, collagen2021-01-25Product approval · Class 4제허 21-60 호
- MFDSBone graft, human sourceRevoked2020-11-03Product approval · Class 4제허 20-928 호
- MFDSSizer, breast prosthesis2020-10-15Product approval · Class 2제인 20-4931 호
- FDAMINT Product Family2020-09-09
- MFDSTissue reconstructive material, synthetic, silicone, block2020-08-21Product approval · Class 3제허 20-688 호
- MFDSPolydioxanone suture2019-11-19Product approval · Class 4제허 19-739 호
- MFDSSizer, breast prosthesis2019-11-13Product approval · Class 2제인 19-4933 호
- MFDSDressing, fluid-impermeable film2019-11-08Product approval · Class 2제인 19-4916 호
- MFDSPolyglycolic acid sutureRevoked2019-07-17Product approval · Class 4제허 19-465 호
- MFDSSuture, polyglecaproneRevoked2019-07-17Product approval · Class 4제허 19-463 호
- MFDSHair implant system2019-06-13Product approval · Class 2제인 19-4473 호
- MFDSSubsidiary: 한스케어 주식회사Nasal splint, external2018-12-31Product approval · Class 1제신 18-1740 호
- MFDSNeedle, suture, general-purposeRevoked2018-08-01Product approval · Class 1제신 18-978 호
- MFDSTissue reconstructive material, synthetic, silicone, block2018-04-17Product approval · Class 3제허 18-261 호
- MFDSGraft/prosthesis, biomaterial2018-04-11Product approval · Class 4제허 18-245 호
- MFDSTissue supplement, collagen2018-03-22Product approval · Class 4제허 18-191 호
- MFDSTissue reconstructive material, synthetic, silicone, block2018-02-26Product approval · Class 3제허 18-123 호
- FDASurFuse Gel, SurFuse Putty, ExFuse Gel, ExFuse Putty2018-02-22
- MFDSBreast prosthesis, internal, gel-filled2017-11-21Product approval · Class 4제허 17-887 호
- MFDSGraft/prosthesis, biomaterial2017-09-13Product approval · Class 4제허 17-698 호
- MFDSBone graft, human source2017-08-31Product approval · Class 4제허 17-663 호
- MFDSTissue reconstructive material, synthetic, silicone, block2017-04-27Product approval · Class 3제허 17-292 호
- MFDSBone graft, human source2017-02-16Product approval · Class 4제허 17-120 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2016-11-15Product approval · Class 4제허 16-847 호
- MFDSHemostat, internal, absorbableRevoked2016-11-02Product approval · Class 4제허 16-796 호
- MFDSDressing, fluid-impermeable film2016-09-02Product approval · Class 2제인 16-4723 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2016-06-20Product approval · Class 4제허 16-436 호
- MFDSTrocar2016-04-28Product approval · Class 1제신 16-519 호
- MFDSNeedle, suture, general-purpose2016-04-27Product approval · Class 1제신 16-517 호
- FDAMaxiGen2016-04-21
- MFDSBreast prosthesis, internal, gel-filled2016-04-21Product approval · Class 4제허 16-308 호
- MFDSBone graft, human source2016-04-18Product approval · Class 4제허 16-303 호
- FDABellaFuse2016-03-11
- MFDSTissue supplement, collagen2016-02-05Product approval · Class 4제허 16-99 호
- MFDSGraft/prosthesis, biomaterial2015-12-03Product approval · Class 4제허 15-1640 호
- MFDSBreast prosthesis, internal, gel-filled2015-11-27Product approval · Class 4제허 15-1620 호
- MFDSBone graft, human sourceRevoked2015-11-25Product approval · Class 4제허 15-1617 호
- MFDSSizer, breast prosthesis2015-08-31Product approval · Class 2제인 15-4085 호
- MFDSSuture, absorbableRevoked2015-06-08Product approval · Class 4제허 15-895 호
- MFDSBone graft material, human source2015-04-24Product approval · Class 4제허 15-634 호
- MFDSDressing, fluid-impermeable film2015-03-11Product approval · Class 2제인 15-350 호
- MFDSGraft, bone, syntheticRevoked2014-07-27Product approval · Class 4제허 14-1390 호
- MFDSGraft, bone, syntheticRevoked2014-07-27Product approval · Class 4제허 14-1391 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2014-06-25Product approval · Class 4제허 14-1219 호
- MFDSDressing, fluid-impermeable filmRevoked2014-06-17Product approval · Class 2제인 14-1180 호
- MFDSGraft, bone, syntheticRevoked2014-05-22Product approval · Class 4제허 14-1062 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbable2014-05-22Product approval · Class 4제허 14-1065 호
Showing the 80 most recent of 156 records.
R&D and key agreements
Source: DART corporate disclosure조직공학 및 신의료기술 R&D · 혈관지혈장치 등 · 연구개발 진행중 · R&D in tissue engineering and new medical technologies including vascular hemostatic devices at company and affiliate research centers
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Response to: Can 8-week Male Rat Data Guide Female Facial Thread Lifts?
Aesthetic plastic surgery · 2026-08 · Le LTT, Giang NN, Trinh TT 외 8
- Comparative Analysis of Collagen Induction in Sprague Dawley Rat Model Using Absorbable Threads for Facial Lifting and Rejuvenation.
Aesthetic plastic surgery · 2026-03 · Le LTT, Giang NN, Trinh TT 외 8
Patents
KIPRIS · applicant-matchedRegistered · 2026-03 · Application 1020260044561
PCT · Published · 2026-01 · Application PCT/KR2026/001020
PCT · Published · 2026-01 · Application PCT/KR2026/000921
PCT · Published · 2025-12 · Application PCT/KR2025/021174
Published · 2025-12 · Application 1020250194422
US · Published · 2025-11 · Application 19392576
Registered · 2025-11 · Application 1020250174482
Published · 2025-02 · Application 1020250013880
Registered · 2025-02 · Application 1020250013883
Registered · 2025-02 · Application 1020250013884
Show 94 more patents
Published · 2024-12 · Application 1020240194378
PCT · Published · 2024-12 · Application PCT/KR2024/020526
PCT · Published · 2024-12 · Application PCT/KR2024/019983
Registered · 2024-11 · Application 1020240164296
PCT · Published · 2024-09 · Application PCT/KR2024/014056
Registered · 2024-09 · Application 1020240126178
Published · 2024-08 · Application 1020240116901
Published · 2024-05 · Application 1020240071029
PCT · Published · 2024-05 · Application PCT/KR2024/095770
Published · 2024-04 · Application 1020240050648
Published · 2023-06 · Application 1020230079693
Registered · 2023-06 · Application 1020230073049
PCT · Published · 2023-06 · Application PCT/KR2023/007670
PCT · Published · 2023-03 · Application PCT/KR2023/003250
PCT · Published · 2023-03 · Application PCT/KR2023/003251
Registered · 2022-08 · Application 1020220099893
PCT · Published · 2022-07 · Application PCT/KR2022/010808
PCT · Published · 2022-07 · Application PCT/KR2022/010806
PCT · Published · 2022-07 · Application PCT/KR2022/010531
PCT · Published · 2022-06 · Application PCT/KR2022/009439
Rejected · 2022-06 · Application 1020220076927
Registered · 2022-06 · Application 1020220072337
Registered · 2022-04 · Application 1020220045046
Registered · 2022-04 · Application 1020220045045
- Subsidiary: 주식회사 한스파마탯줄 유래 중간엽 줄기세포 배양액을 유효성분으로 포함하는 피부 개선용 조성물
Registered · 2022-03 · Application 1020220037998
PCT · Published · 2021-12 · Application PCT/KR2021/018543
Registered · 2021-10 · Application 1020210145861
Registered · 2021-10 · Application 1020210145862
Registered · 2021-08 · Application 1020210108181
Registered · 2021-07 · Application 1020210096608
Rejected · 2021-07 · Application 1020210096645
Rejected · 2021-07 · Application 1020210096646
Registered · 2021-07 · Application 1020210094308
- Subsidiary: 주식회사 한스파마탯줄 유래 중간엽 줄기세포로부터 분리된 엑소좀을 포함하는 피부 개선용 화장료 조성물
Registered · 2021-05 · Application 1020210067567
PCT · Published · 2021-04 · Application PCT/KR2021/004901
US · Published · 2021-03 · Application 18016302
EP · Published · 2021-03 · Application 21842462.0
PCT · Published · 2021-03 · Application PCT/KR2021/002572
Registered · 2021-01 · Application 1020210006286
Registered · 2020-12 · Application 1020200173672
PCT · Published · 2020-10 · Application PCT/KR2020/013730
Registered · 2020-08 · Application 1020200102695
US · Published · 2020-07 · Application 17627358
PCT · Published · 2020-07 · Application PCT/KR2020/009445
Registered · 2020-07 · Application 1020200089178
- Subsidiary: 주식회사 한스파마신경줄기세포 배양액을 유효성분으로 포함하는 피부 개선용 조성물
Registered · 2020-05 · Application 1020200061775
Registered · 2020-04 · Application 1020200051633
Rejected · 2020-03 · Application 1020200026289
PCT · Published · 2020-02 · Application PCT/KR2020/001967
- Subsidiary: 주식회사 한스파마신경줄기세포의 제조방법 및 이로부터 얻어진 신경줄기세포 배양액을 유효성분으로 포함하는 피부 재생, 항산화, 항염증 및 상처 치료용 조성물
Registered · 2020-02 · Application 1020200015083
Registered · 2019-08 · Application 1020190101248
Registered · 2019-07 · Application 1020190086632
Registered · 2019-05 · Application 1020190054513
Registered · 2018-12 · Application 1020180172555
Registered · 2018-06 · Application 1020180069527
Registered · 2017-12 · Application 1020170175807
PCT · Published · 2017-10 · Application PCT/KR2017/011886
Rejected · 2017-09 · Application 1020170112759
Registered · 2017-03 · Application 2020170001340
Expired · 2012-11 · Application 1020120127689
Registered · 2012-04 · Application 1020120038409
Registered · 2011-10 · Application 1020110107351
Registered · 2011-08 · Application 1020110087155
CN · Published · 2011-08 · Application 201180012052
Rejected · 2011-04 · Application 1020110040232
Registered · 2011-03 · Application 1020110026122
Rejected · 2011-01 · Application 1020110001967
Registered · 2010-10 · Application 1020100102493
Registered · 2010-08 · Application 1020100079006
Registered · 2010-07 · Application 1020100072092
Registered · 2010-06 · Application 1020100059730
Rejected · 2010-04 · Application 1020100038030
Registered · 2010-01 · Application 1020100002281
Registered · 2009-06 · Application 1020090052860
Registered · 2009-04 · Application 1020090038257
Registered · 2009-03 · Application 1020090020692
Rejected · 2008-10 · Application 1020080106286
Registered · 2008-09 · Application 1020080091084
Rejected · 2008-09 · Application 1020080088785
Rejected · 2008-04 · Application 1020080033800
Rejected · 2008-04 · Application 1020080033801
Registered · 2007-09 · Application 1020070091639
Expired · 2007-05 · Application 2020070008355
Registered · 2007-01 · Application 1020070004362
Rejected · 2007-01 · Application 2020070000747
Registered · 2007-01 · Application 1020070004364
PCT · Published · 2006-11 · Application PCT/KR2006/005123
Registered · 2006-09 · Application 1020060095322
Expired · 2006-03 · Application 2020060008344
Expired · 2006-03 · Application 1020060028387
PCT · Published · 2002-09 · Application PCT/KR2002/001679
Expired · 2002-09 · Application 1020027012668
Rejected · 2001-11 · Application 1020010074398
Expired · 2000-03 · Application 1020000015768
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive5
- OpenAIOAI-SearchBot93
- GoogleGoogleOther8
- PerplexityPerplexityBot4
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for HANS BIOMED CORPORATION and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.
KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.
Founded and KOSPI-listed in 2025, Samyang Biopharm develops medical devices, pharmaceuticals, and new drug candidates.
Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.
KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.
Founded in 1997 and KOSDAQ-listed in 2015, CG MedTech makes orthopedic medical devices and also operates an electric energy business.
Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.
L&C BIO manufactures human tissue grafts across 11 tissue types, including the acellular dermal matrix MegaDerm, plus tissue-based medical devices.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition